SCHEMBL30857996

SCHEMBL30857996

Cc1cc2c(=O)cc(-c3ccncc3)oc2c(Br)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 8/20 0.53
▸ CYP1B1 Q16678 8/20 0.53
▸ CYP1A2 P05177 7/20 0.53
▸ CFTR P13569 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ CYP3A4 P08684 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ NCOA1 Q15788 1/20 0.50
▸ NCOA3 Q9Y6Q9 1/20 0.50
▸ PIK3CD O00329 1/20 0.47
▸ PIK3CA P42336 1/20 0.47
▸ PIK3CB P42338 1/20 0.47
▸ PIK3CG P48736 1/20 0.47
▸ QPCT Q16769 1/20 0.46
▸ CSNK2A2 P19784 4/20 0.45
▸ CSNK2B P67870 4/20 0.45
▸ CSNK2A1 P68400 4/20 0.45
▸ KDM4E B2RXH2 2/20 0.39
▸ PRKDC P78527 2/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30857984 0.80 PIK3CD (0.49) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL910015 0.80 PIK3CD (0.57) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL30857940 0.75 CYP1A2 (0.47) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL30564360 0.74 MAPT (0.39) POLBCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL12904313 0.74 PIK3CD (0.56) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL25260798 0.73 CYP1A2 (0.64) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL30461668 0.73 CYP1A2 (0.64) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL909859 0.73 PIK3CD (0.67) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL909776 0.71 PIK3CD (0.54) CYP1A1CYP1B1CYP1A2CFTRPOLB
SCHEMBL910336 0.70 PIK3CD (0.67) CYP1A1CYP1B1CYP1A2CFTRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4602031-A1 METHODS FOR TREATING CANCER Genesis Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
WO-2024081904-A1 METHODS FOR TREATING CANCER GENESIS THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback